Fibrinogen and fibrin clot structure in diabetes

Herz
Emma J Dunn, Robert A S Ariëns

Abstract

Diabetes is associated with an increased risk of developing cardiovascular disease, which is not fully accounted for by the accumulation of classic cardiovascular risk factors in patients. Recent evidence has demonstrated fibrinogen to be a powerful independent risk marker for cardiovascular disease in the general population, and it is also likely to contribute toward the increased atherosclerotic risk in diabetes. The etiology of hyperfibrinogenemia in diabetes is likely to be multifactorial, and at present the mechanisms involved have not been clarified. However, insulin, insulin resistance and inflammation are likely to be involved, especially in type 2 diabetes. The influence of diabetes in determining an individual's atherothrombotic risk is likely to extend beyond that of elevated fibrinogen levels, and may also act via changes in the structure and function of the fibrin clot that forms. Further research is needed to determine the mechanisms underlying these changes, which may lead to development of future interventions to reduce the excessive vascular risk associated with this disease.

Citations

Apr 12, 2011·Thrombosis and Haemostasis·Katharina Hess, Peter J Grant
Aug 30, 2008·Blood Reviews·R A Ajjan, R A S Ariëns
Jun 6, 2014·Thrombosis and Haemostasis·Katherine I BridgeRobert A S Ariëns
Mar 26, 2014·Arthritis & Rheumatology·Heather A ColeJonathan G Schoenecker
Jun 21, 2005·Blood Reviews·Kristina F StandevenPeter J Grant
Dec 14, 2005·Atherosclerosis·Ramzi Ajjan, Peter J Grant
Apr 19, 2007·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Etheresia PretoriusCarl Franz
Nov 9, 2007·Diabetes/metabolism Research and Reviews·Antonio Ceriello
Dec 15, 2007·Molecular Nutrition & Food Research·Marlien Pieters, Hester H Vorster
Nov 19, 2005·Expert Review of Cardiovascular Therapy·Ramzi A Ajjan, Peter J Grant
Jan 1, 2015·Hämostaseologie·K Hess
Nov 7, 2019·Biochemistry. Biokhimii︠a︡·N GligorijevicO Nedic
Jun 28, 2019·Current Protein & Peptide Science·Shahnawaz RehmanSaheem Ahmad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.